Related Experiment Video
Updated: Jul 17, 2025

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
Published on: February 2, 2021
Designing acute kidney injury clinical trials
Alexander Zarbock1,2, Lui G Forni3,4, Marlies Ostermann5
1Department of Anaesthesiology, Intensive Care and Pain Medicine, University Hospital of Münster, Münster, Germany. zarbock@uni-muenster.de.
Abstract:
Acute kidney injury (AKI) is a common clinical condition with various causes and is associated with increased mortality. Despite advances in supportive care, AKI increases not only the risk of premature death compared with the general population but also the risk of developing chronic kidney disease and progressing towards kidney failure. Currently, no specific therapy exists for preventing or treating AKI other than mitigating further injury and supportive care. To address this unmet need, novel therapeutic interventions targeting the underlying pathophysiology must be developed. New and well-designed clinical trials with appropriate end points must be subsequently designed and implemented to test the efficacy of such new interventions. Herein, we discuss predictive and prognostic enrichment strategies for patient selection, as well as primary and secondary end points that can be used in different clinical trial designs (specifically, prevention and treatment trials) to evaluate novel interventions and improve the outcomes of patients at a high risk of AKI or with established AKI.
Insights
Acute kidney injury (AKI) is a serious condition with no specific treatments. This study proposes new clinical trial designs and patient selection strategies to develop effective AKI therapies.
Area of Science:
- Nephrology
- Clinical Trials
- Translational Medicine
Background:
- Acute kidney injury (AKI) is a prevalent clinical syndrome linked to high mortality and progression to chronic kidney disease.
- Current management of AKI relies on supportive care, with no specific therapies available to prevent or treat the condition.
- There is a critical need for novel therapeutic interventions targeting AKI's underlying mechanisms.
Purpose of the Study:
- To discuss strategies for patient selection in clinical trials for AKI.
- To outline appropriate endpoints for evaluating novel AKI interventions.
- To guide the design of future prevention and treatment trials for AKI.
Main Methods:
- Review of predictive and prognostic enrichment strategies for AKI patient selection.
- Discussion of primary and secondary endpoints for AKI clinical trials.
- Consideration of trial designs for both AKI prevention and treatment.
Main Results:
- Enrichment strategies can identify high-risk patients for AKI trials.
- Carefully chosen endpoints are crucial for demonstrating intervention efficacy.
- Tailored trial designs are necessary for different AKI contexts.
Conclusions:
- Developing novel AKI therapies requires innovative clinical trial designs.
- Effective patient selection and endpoint definition are key to successful AKI research.
- Improved trial methodologies will advance AKI patient outcomes.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury VI: Nursing Management
Acute Kidney Injury II: Pathophysiology

